Cell therapy anito-cel shows promise for hard-to-treat RRMM
Most people with relapsed or refractory multiple myeloma…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreMost people with relapsed or refractory multiple myeloma…
The cell therapy Carvykti (ciltacabtagene autoleucel) — approved earlier…
Researchers in Belgium have developed an atlas to…
The U.S. Food and Drug Administration (FDA) will review…
A combination therapy using Blenrep (belantamab mafodotin) was more…
A standard autologous hematopoietic stem cell transplant (AHSCT)…